These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 24367157)

  • 1. Review: the history and role of naturally occurring mouse models with Pde6b mutations.
    Han J; Dinculescu A; Dai X; Du W; Smith WC; Pang J
    Mol Vis; 2013 Dec; 19():2579-89. PubMed ID: 24367157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a novel Pde6b-deficient rat model of retinal degeneration and treatment with adeno-associated virus (AAV) gene therapy.
    Han IC; Wiley LA; Ochoa D; Lang MJ; Harman BE; Sheehan KM; Mullins RF; Stone EM; Tucker BA
    Gene Ther; 2023 Apr; 30(3-4):362-368. PubMed ID: 36175490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AAV-mediated gene replacement, either alone or in combination with physical and pharmacological agents, results in partial and transient protection from photoreceptor degeneration associated with betaPDE deficiency.
    Allocca M; Manfredi A; Iodice C; Di Vicino U; Auricchio A
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5713-9. PubMed ID: 21273543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advancing Gene Therapy for PDE6A Retinitis Pigmentosa.
    Petersen-Jones SM; Occelli LM; Biel M; Michalakis S
    Adv Exp Med Biol; 2019; 1185():103-107. PubMed ID: 31884596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically modified neural stem cells for a local and sustained delivery of neuroprotective factors to the dystrophic mouse retina.
    Jung G; Sun J; Petrowitz B; Riecken K; Kruszewski K; Jankowiak W; Kunst F; Skevas C; Richard G; Fehse B; Bartsch U
    Stem Cells Transl Med; 2013 Dec; 2(12):1001-10. PubMed ID: 24167317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mid-stage intervention achieves similar efficacy as conventional early-stage treatment using gene therapy in a pre-clinical model of retinitis pigmentosa.
    Wert KJ; Sancho-Pelluz J; Tsang SH
    Hum Mol Genet; 2014 Jan; 23(2):514-23. PubMed ID: 24101599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study of PDE6B gene mutation and phenotype in Chinese cases with retinitis pigmentosa].
    Cui Y; Zhao KX; Wang L; Wang Q; Zhang W; Chen WY; Wang LM
    Zhonghua Yan Ke Za Zhi; 2003 Jan; 39(1):28-32. PubMed ID: 12760810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late-stage rescue of visually guided behavior in the context of a significantly remodeled retinitis pigmentosa mouse model.
    Kajtna J; Tsang SH; Koch SF
    Cell Mol Life Sci; 2022 Feb; 79(3):148. PubMed ID: 35195763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Success of Gene Therapy in Late-Stage Treatment.
    Koch SF; Tsang SH
    Adv Exp Med Biol; 2018; 1074():101-107. PubMed ID: 29721933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable phenotypic expressivity in inbred retinal degeneration mouse lines: A comparative study of C3H/HeOu and FVB/N rd1 mice.
    van Wyk M; Schneider S; Kleinlogel S
    Mol Vis; 2015; 21():811-27. PubMed ID: 26283863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AKT3 Gene Transfer Promotes Anabolic Reprogramming and Photoreceptor Neuroprotection in a Pre-clinical Model of Retinitis Pigmentosa.
    McDougald DS; Papp TE; Zezulin AU; Zhou S; Bennett J
    Mol Ther; 2019 Jul; 27(7):1313-1326. PubMed ID: 31043342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The manner of decay of genetically defective EYS gene transcripts in photoreceptor-directed fibroblasts derived from retinitis pigmentosa patients depends on the type of mutation.
    Seko Y; Iwanami M; Miyamoto-Matsui K; Takita S; Aoi N; Umezawa A; Kato S
    Stem Cell Res Ther; 2018 Oct; 9(1):279. PubMed ID: 30359287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lentivirus-mediated expression of cDNA and shRNA slows degeneration in retinitis pigmentosa.
    Tosi J; Sancho-Pelluz J; Davis RJ; Hsu CW; Wolpert KV; Sengillo JD; Lin CS; Tsang SH
    Exp Biol Med (Maywood); 2011 Oct; 236(10):1211-7. PubMed ID: 21885480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two mouse retinal degenerations caused by missense mutations in the beta-subunit of rod cGMP phosphodiesterase gene.
    Chang B; Hawes NL; Pardue MT; German AM; Hurd RE; Davisson MT; Nusinowitz S; Rengarajan K; Boyd AP; Sidney SS; Phillips MJ; Stewart RE; Chaudhury R; Nickerson JM; Heckenlively JR; Boatright JH
    Vision Res; 2007 Mar; 47(5):624-33. PubMed ID: 17267005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of vision in the pde6β-deficient dog, a large animal model of rod-cone dystrophy.
    Petit L; Lhériteau E; Weber M; Le Meur G; Deschamps JY; Provost N; Mendes-Madeira A; Libeau L; Guihal C; Colle MA; Moullier P; Rolling F
    Mol Ther; 2012 Nov; 20(11):2019-30. PubMed ID: 22828504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Screening gene mutations of the beta subunit of phosphodiesterase in the Chinese retinitis pigmentosa patients].
    Cui Y; Wang L; Zhao KX; Wang Q; Chen WY; Wang LM
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Jun; 20(3):200-2. PubMed ID: 12778443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autosomal-recessive early-onset retinitis pigmentosa caused by a mutation in PDE6G, the gene encoding the gamma subunit of rod cGMP phosphodiesterase.
    Dvir L; Srour G; Abu-Ras R; Miller B; Shalev SA; Ben-Yosef T
    Am J Hum Genet; 2010 Aug; 87(2):258-64. PubMed ID: 20655036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term retinal function and structure rescue using capsid mutant AAV8 vector in the rd10 mouse, a model of recessive retinitis pigmentosa.
    Pang JJ; Dai X; Boye SE; Barone I; Boye SL; Mao S; Everhart D; Dinculescu A; Liu L; Umino Y; Lei B; Chang B; Barlow R; Strettoi E; Hauswirth WW
    Mol Ther; 2011 Feb; 19(2):234-42. PubMed ID: 21139570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential of Small Molecule-Mediated Reprogramming of Rod Photoreceptors to Treat Retinitis Pigmentosa.
    Nakamura PA; Tang S; Shimchuk AA; Ding S; Reh TA
    Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):6407-6415. PubMed ID: 27893103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy restores vision and delays degeneration in the CNGB1(-/-) mouse model of retinitis pigmentosa.
    Koch S; Sothilingam V; Garcia Garrido M; Tanimoto N; Becirovic E; Koch F; Seide C; Beck SC; Seeliger MW; Biel M; Mühlfriedel R; Michalakis S
    Hum Mol Genet; 2012 Oct; 21(20):4486-96. PubMed ID: 22802073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.